The clonogenic growth of myeloid leukemia cell lines was inhibited by recombinant tumor necrosis factor (rTNF) at 1-15 pM concentration. However, wild type (promyelocytic) HL-60 cells were highly resistant to growth inhibition, but responded with differentiation into monocyte-like cells at 100 pM rTNF. The clonogenic growth of fresh acute myeloid leukemia cells was inhibited by 50% at '-15 pM rTNF. The growth of normal granulocyte-macrophage progenitors (CFU-GM) was also inhibited (by 50 pM rTNF), as was the growth of erythroid progenitors (BFU-E) (by 150 pM rTNF). A synergistic antiproliferative effect was demonstrated between rTNF and recombinant interferon-'y. Use of radioiodinated rTNF enabled us to detect 1,500-2,100 binding sites on myeloid cell lines at 4VC with Kd of -300 pM. At 370C, the transfer of bound ligand to lysosomes was followed by degradation, inhibited by NH4'. No correlation was observed between the number of binding sites or affinity at 4°C and antiproliferative response to the addition of rTNF.
Introduction
Biologically active polypeptides such as lymphokines and monokines may be of use in fighting leukemia because of their ability to inhibit proliferation and induce differentiation. We (1, 2) and others (3, 4) have demonstrated that T-lymphocytes can produce polypeptides called differentiation-inducing factors (DIF)' that induce differentiation of the promyelocytic cell line. In addition, DIF caused a primary growth inhibition of other hemopoietic cell lines (Gullberg U., E. Nilsson, M. G. Sarngadharan, and I. Olsson, submitted for publication.).
Therefore we have now investigated whether the cytotoxic and cytostatic factor, tumor necrosis factor (TNF), has similar properties, and we have tried to relate the effects observed to TNF binding to the cell surface of hemopoietic cells. 1 . Abbreviations used in this paper: AML, acute myeloid leukemia; BFU-E, erythroid progenitor, CFU-GM, granulocyte-macrophage progenitor; DIF, differentiation-inducing factor, FBS, fetal bovine serum; IFN-'y, interferon-y; NBT, nitroblue tetrazolium; rTNF, recombinant tumor necrosis factor, SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; TNF, tumor necrosis factor. TNF, detected in serum of mice and rabbits injected with bacillus Calmette-Guerin and endotoxin (5) , is produced by macrophages (6) . Also lymphotoxin, produced by some EpsteinBarr virus-transformed B cell lines after exposure to a phorbol ester, is active in the classical tumor necrosis assay (7) . The promyelocytic HL-60 (8, 9) and the monoblastic U-937 (8) cell lines secrete TNF when stimulated with phorbol esters. TNF was purified, and synthetic oligonucleotides corresponding to a partial amino acid sequence were used for isolation and cloning of TNF cDNA (9-1 1). As a result, human recombinant TNF (rTNF) was produced in Escherichia coli (8) (9) (10) (11) . The gene that encodes TNF was identified in a genomic library (11, 12) . It seems that TNF belongs to a family ofpolypeptides with similar biological activities. Thus the gene coding for the cytotoxic factor lymphotoxin was cloned, and the sequence comparison revealed extensive homologies (13) between TNF and lymphotoxin. A factor called cachectin, which is produced in macrophages and specifically suppresses the enzyme lipoprotein lipase in adipocytes, may be identical with TNF (14) . Cachectin inhibits the activity of fat-producing (lipogenic) enzymes in cultured adipocytes (15) . It may play a role in the development of cachexia in chronic inflammatory disease.
The proliferative response to TNF was reported to vary among carcinoma and sarcoma cell lines (16) and did not correlate to the number of binding sites per cell. High-affinity receptors for TNF have been demonstrated on HeLa and lymphoblastoid cells, which are sensitive to TNF-mediated growth inhibition (17, 18) . Preincubation of cells with interferon-y increased the number of TNF receptors (19 Assays for differentiation and growth inhibition. For differentiation assays, 1-ml aliquots 2 X 105/ml wild type HL-60 (passage 20-45) were incubated with rTNF. After 4 d, the cell number, viability, number of nonspecific esterase-positive cells with a-naphthyl butyrate as substrate (24) , and number ofcells with a capacity to reduce nitroblue tetrazolium (NBT) were determined (2) .
The growth-inhibitory effect of TNF on cell lines was determined by use of agar culture. In the latter, 2,000 cells were seeded in 1 ml of 0.3% agar on top of 1 ml of0.5% agar in 35-mm tissue culture dishes. Colonies were counted after 10 d.
Assayfor granulocyte-macrophage progenitors (CFU-GM). Human marrow cells (10) with d <1.077 g/ml, obtained by centrifugation in Ficoll-Hypaque was grown in 1 ml of 0.3% agar on top of I ml of 0.5% agar in growth medium with 15% FBS in 35-mm tissue culture dishes. As a source ofcolony stimulating activity, human placenta-conditioned medium was used after partial purification by chromatography on Sephadex G-75 (Pharmacia Co., Sweden). The plates were scored after 7, 10, and 14 d. The effects of TNF on colonies counted on day 10 are documented in (26) after 20 d. The single compact colony type composed a minority of the erythroid growth from peripheral blood mononuclear cells. These were also counted as BFUJ-E as described (26). Both types ofBFU-E consisted of more than 500 cells. Control incubations without TNF contained 86±49.7 (SD) BFU-E/dish.
Iodination of TNF. Iodination was performed using the two-phase method described by Tejedor and Ballasta (27) . Borate buffer (50 Ml, 50 mM, pH 8.4), KI (10 Ml, 0.125 mM in borate buffer) and 1 mCi of carrier-free 1251 (Amersham International, Amersham, Buckinghamshire, England) were mixed with 2 Ag rTNF containing 0.05% Tween 20. Iodination was performed as described (27) . A Sephadex G-25 column was used for isolation of the 1251-rTNF. 125I was incorporated into rTNF without loss of biological activity, as judged by its ability to inhibit the clonogenic growth of HL-60-l0. The specific activity of '25I-rTNF was determined by self displacement analysis (28) . For this analysis, it is assumed that the binding characteristics of labeled and unlabeled rTNF are the same.
The iodinated rTNF was subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as described previously (2) . After electrophoresis gels were dried on filter paper, they were exposed to x-ray film (X-Omat S, Eastman Kodak Co., Rochester, NY) for 12 h.
Binding of'25I-rTNF to cells. Washed cells were incubated with radioiodinated rTNF in binding buffer (RPMI, 2% heat-inactivated FBS, and 1% BSA) in a total volume of 200 Ml in 1.5-ml Eppendorf centrifuge tubes. After incubation by rotation, cells were centrifugated for 10 s at 8,000 g, and the pellet was resuspended and washed twice in ice-cold binding buffer to separate free and membrane-bound '25I-rTNF. The radioactivity of the cell pellet was measured in a y-counter. Specific binding was defined as the difference between total binding and the binding that occurred in the presence of a 20-fold excess of unlabeled rTNF (nonspecific binding). In the range of 2 X I06-20 X 106 cells, the assay was proportional to the number of cells added. In standard assays, 5 X 106 cells were used per incubation.
The occurrence ofdegradation products of 125I-rTNF in the incubation medium upon binding and internalization of 125I-rTNF was also determined. The incubation medium was precipitated with 10% trichloroacetic acid. The radioactivity of the supernatant was determined and taken as a measure of degraded 1251I-rTNF.
Subcellularfractionation. Before homogenization of labeled cells, 5 X 10' unlabeled carrier cells were added. Homogenization was at a concentration of 108 cells/ml in 0.34 M sucrose/5 mM Hepes (pH 7.3)/0.5 mM EDTA (homogenization medium) with 40 strokes of a Dounce glass homogenizer (Kontes Glass Co., Vineland, NJ). The homogenate was diluted with the same solution and unbroken cells and nuclei were recovered by centrifugation at 700 g for 10 min. For density gradient separations, 6 ml of 12% Percoll (density 1.069 g/ml), in Hepes/sucrose adjusted to give a final concentration of 15- (Fig. 2) . There was an increase in a-NBE-positive cells too, indicating maturation along the monocyte-macrophage pathway, which was supported also by alterations in cell morphology with the appearance ofirregular nuclei and disappearance of cytoplasmic granulation. These changes occurred at 2-4 d of incubation at 100-600 pM concentration ofrTNF. The maturation changes took place without inhibition of growth during the first 4 d of incubation (data not shown).
Proliferation inhibition of myeloid cell lines. One subclone of HL-60 (HL-60-10) was highly susceptible to the antiproliferative effect of rTNF in a clonal assay (agar culture). 1 pM rTNF inhibited growth 50% (Fig. 1) . TNF did not induce visible differentiation of HL-60-10 cells; judging from the fact that no NBT-positive cells were formed. In separate experiments (data not shown), we investigated if the growth inhibitory effect on HL-60-10 was reversible or not in suspension culture. We found that if rTNF was removed from the cells by washing within 24 h of addition, the effect was partly reversible. In contrast to wild type HL-60, subclones, e.g., HL-60-l0, sensitive to TNF-induced growth inhibition, were a-NBE-positive. In this respect the subclones are similar to the monoblast-like U-937 cell line, which was also highly susceptible to rTNF-induced growth inhibition, with 50% inhibition at a concentration of rTNF below 1 pM (Fig. 1) . The myeloblast-like KG-1 cell line was also highly susceptible to rTNF, while the proerythroid K-562 line was less susceptible.
Proliferation inhibition ofnormal hemopoietic cells andfresh AML cells. Fig. 1 shows that normal CFU-GM responded with growth inhibition to the addition of rTNF with 50% inhibition at 50 pM rTNF. BFU-E were less susceptible than CFU-GM. Synergistic antiproliferative effect ofrTNF and rIFN-,y. The combined effect of rTNF and rIFN-y on the clonogenic growth of HL-60-10 was investigated (Fig. 3) . rIFN-'y, 100-500 U/ml, did not significantly inhibit growth. However, additions of 100-500 U/ml ofrIFN-'y clearly potentiated the antiproliferative effect ofrTNF, thus indicating a synergistic action between rTNF and rIFN-'y. This result is consistent with results from a previous report on synergism between rTNF and rIFN-'y for proliferation inhibition on human carcinoma cell lines (16) .
Binding of25I-rTNF to hemopoietic cells. TNF was iodinated with a two-phase labeling system (27) . When iodinated rTNF was subjected to SDS-PAGE, a major Mr 17,000 component was visible on the fluorogram (Fig. 4) . The specific activity was determined by self-displacement analysis (Fig. 4) of HL-60-10 cells. This method gives an estimate of the specific radioactivity of the TNF molecules that actually bind to the target cells in the assay. The parallel displacement curves for the total rTNF and unlabeled rTNF (Fig. 4) indicated that the binding affinity of iodinated and native TNF molecules was similar. This was obvious also from titration experiments where the growth-inhibitory effects of iodinated rTNF and unlabeled rTNF were compared (data not shown). The self-displacement analysis gave an estimate of the specific activity of 2.1 X 106 cpm/pmol.
The competition for '25I-rTNF binding to hemopoietic cell lines by unlabeled rTNF is shown in Fig. 5 The finding of a temperature-dependent degradation ofcellassociated 125VIrTNF suggested that rTNF may be degraded after receptor-mediated endocytosis and fusion of receptosomes with lysosomes. Using a Percoll density gradient system, we attempted to determine if bound rTNF resided either within a vesicular compartment in the cell or remained bound to membrane. The gradient system allowed separation oflysosomes from Golgi and plasma membrane fractions. The positions of these fractions were determined by marker enzymes (Fig. 7 A) . Cells were loaded with '251-rTNF at 40 or 370C. After loading at 40C for 60 min, cells were homogenized at 0C and added to Percoll for gradient centrifugation at 4VC. The 1251I-rTNF was present in a fraction that corresponded exactly with the localization ofplasma membranes (Fig. 7 B) . No delivery to denser organelles was seen. However, loading for 30 min at 370C resulted in the occurrence of labeled material in the most dense fractions corresponding to the distribution of lysosomes and a clear decrease of plasma membrane-associated 125I-rTNF. Increased loading times resulted in an increase in radioactivity in the most dense fractions and a decrease in the light fractions. These data demonstrate that 125I-rTNF is internalized, and it is also degraded at least in part, according to data of Fig. 6 .
We attempted to obtain more detailed information on internalization and degradation of '25I-rTNF by modulating these processes by several means (Fig. 7 C) . Internalization was not blocked by 10 gM colchicine, which disrupts microtubules. Moreover 10 gg/ml cytochalasin B, which disrupts microfilaments, did not block internalization either (data not shown). Thus internalization does not require an intact cytoskeleton. Monensin, a monocarboxylic proton ionophore that exchanges Na' ions for protons and raises the normally acidic pH of endocytic vacuoles (34), did not interfere with internalization (Fig.  7 C) . 10 mM NHICl did not block internalization either (Fig.  7 C) . In contrast to NH4', incubation with monensin and chloroquine did not inhibit the degradative pathway resulting in the intracellular accumulation of intact ligand without release of acid-soluble degradation products to the medium (data not shown). A of -300 pM with 1,500-2,100 binding sites per cell. Table I summarizes data for HL-60 and HL-60-10 at various temper--1.070
atures. Wild type HL-60 showed homogeneous binding at 40, 230 , and 370C, whereas HL-60-10 showed bimodal binding at higher temperatures. Thus a small number of"very high" affinity - Thus the number of high affinity sites was similar in various cell lines at 4VC, and the binding sites had a similar affinity for the ligand in various cell lines, whereas the growth-inhibitory effect of TNF varied considerably (Fig. 1) . Obviously the antiproliferative effect on the cell lines was not reflected in variations of the number of binding sites or affinity of the receptor at 40C. However, the "very high" affinity binding demonstrated at elevated temperature was not observed in wild type HL-60 cells, c which were highly insensitive to the antiproliferative effect.
Percoll density gradient centrifugation of cell homogenates revealed that internalization of bound ligand occurred equally well in wild type HL-60 and HL-60-10 (data not shown). Thus differences in internalization rates do not explain the different cellular response in wild type HL-60 and HL-60-I0. The cells were incubated at 22 different concentrations (5-800 nM) of '25I-rTNF in the absence or presence of excess unlabeled rTNF to correct for unspecific binding. When more than one experiment was performed, the range of data obtained is given.
cytostatic effect ofsupernatant from natural killer cells on CFU-GM are antigenically, functionally, and biochemically similar to or identical with TNF produced by monocytes (37) . Our data showed that CFU-GM were more sensitive to rTNF than BFU-E. This is consistent with data of a recent abstract on the effect of TNF on human bone marrow hemopoietic progenitor cells (38) . However, some human cancer cell lines (16) (17) (18) and some of the myeloid leukemia cell lines of this report were extremely sensitive to TNF. The mechanism for this potent and selective effect is unknown. A synergistic cytotoxic interaction between TNF and IFN-y reported for human cancer cell lines (7) and hematopoietic progenitors (37, 38) was shown for the myeloid cell lines too. The present data also show binding of rTNF to myeloid cells. Receptor expression was not influenced by cellular differentiation, as uninduced and induced HL-60 cells both demonstrated saturable binding of TNF. Binding of radioiodinated recombinant TNF to myeloid cell lines such as HL-60-I0 and U-937 at 4°C was saturable, reversible, and of high affinity (Kd = 300 pM). The surface-bound ligand was internalized at elevated temperature. Intracellular rTNF was degraded into trichloroacetic acid-soluble material. When binding studies were performed at elevated temperature, the Scatchard plot of the binding data was biphasic. In addition to binding sites detectable at 4°C, the presence of a small number of very high affinity binding sites was suggested. However, this result could also be a consequence ofligand internalization that took place at elevated temperature but not at 4°C. It remains to be determined if purified plasma membranes have two classes of binding sites or not. A similar result was reported for rINF-'y, but isolated plasma membranes bound ligand in a unimodal manner at either 4°or 370C, indicating that only one class ofhigh-affinity receptor was present for IFN-y (39) .
Our data demonstrate that low temperature preferentially inhibited rTNF degradation while endocytic uptake continued at 200C. The results from subcellular fractionation indicated that at 20°C, unlike at 37°C, internalized rTNF did not reach the lysosomes but remained in receptosomes. This agrees with data for the asialoglycoprotein receptor system for which endocytosis also continued at 20°C while lysosomal degradation was completely inhibited (40, 41) . On the other hand endocytic uptake of insulin in adipocytes is more temperature-sensitive than intracellular processing and release of internalized insulin (42) . Thus differences may exist in mechanisms of uptake and degradation of various ligand receptor systems.
Internalization of rTNF was independent of an intact cytoskeleton, as agents that disrupt microfilaments or microtubules did not inhibit the internalization. Transport of ligand to lysosomes seemed to be independent of acidification of endocytic vacuoles, as transport was not blocked by NH4, or monensin. The latter agent, which exchanges Na+ ions for protons, disrupts an ion gradient necessary for the budding of vesicles from the Golgi apparatus and also blocks the movement of newly synthesized plasma membrane proteins from the Golgi to the plasma membrane (34) . Monensin can also block receptor recycling (43) .
TNF receptors have now been found in human and murine carcinoma cell lines (16, 18, 19) , some lymphoblastoid cell lines (17) , and myeloid cells ofthe present study. 
